Details for New Drug Application (NDA): 020857
✉ Email this page to a colleague
The generic ingredient in COMBIVIR is lamivudine; zidovudine. There are twenty-nine drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the lamivudine; zidovudine profile page.
Summary for 020857
Tradename: | COMBIVIR |
Applicant: | Viiv Hlthcare |
Ingredient: | lamivudine; zidovudine |
Patents: | 0 |
Pharmacology for NDA: 020857
Mechanism of Action | Nucleoside Reverse Transcriptase Inhibitors |
Suppliers and Packaging for NDA: 020857
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
COMBIVIR | lamivudine; zidovudine | TABLET;ORAL | 020857 | NDA | ViiV Healthcare Company | 49702-202 | 49702-202-18 | 60 TABLET, FILM COATED in 1 BOTTLE (49702-202-18) |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 150MG;300MG | ||||
Approval Date: | Sep 26, 1997 | TE: | RLD: | Yes |
Expired US Patents for NDA 020857
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Viiv Hlthcare | COMBIVIR | lamivudine; zidovudine | TABLET;ORAL | 020857-001 | Sep 26, 1997 | ⤷ Sign Up | ⤷ Sign Up |
Viiv Hlthcare | COMBIVIR | lamivudine; zidovudine | TABLET;ORAL | 020857-001 | Sep 26, 1997 | ⤷ Sign Up | ⤷ Sign Up |
Viiv Hlthcare | COMBIVIR | lamivudine; zidovudine | TABLET;ORAL | 020857-001 | Sep 26, 1997 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription